ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,667.20
      0.64%
      US Tech 100
      19,612.00
      -1.22%
      Dow Jones
      40,954.48
      1.85%
      Brent Oil
      83.37
      0.07%
      Bitcoin
      65,239.05
      0.22%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSX

      6. Knight Therapeutics Inc (GUD) Quote

      Knight Therapeutics Inc

      Knight Therapeutics Inc (GUD)

      GUD Holdings Limited
      5.79
      0.00
      (0.00%)
      Closed July 17 4:12PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      5.79
      Bid
      5.75
      Ask
      5.87
      Volume
      -
      0.00 Day's Range 0.00
      4.35 52 Week Range 6.22
      Market Cap
      585.774M
      Previous Close
      5.79
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      56,197
      Shares Outstanding
      101,170,000
      Dividend Yield
      -
      PE Ratio
      -34.62
      Earnings Per Share (EPS)
      -0.17
      Revenue
      331.1M
      Net Profit
      -16.84M

      About Knight Therapeutics Inc

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.gudknight.com
      Headquarters
      Montreal, Quebec, Can
      Founded
      1970
      Knight Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the Toronto Stock Exchange with ticker GUD. The last closing price for Knight Therapeutics was $5.79. Over the last year, Knight Therapeutics shares have traded in a share price range of $ 4.35 to $ 6.22.

      Knight Therapeutics currently has 101,170,000 shares outstanding. The market capitalization of Knight Therapeutics is $585.77 million. Knight Therapeutics has a price to earnings ratio (PE ratio) of -34.62.

      GUD Latest News

      More News

      Knight Announces Normal Course Issuer Bid

      MONTREAL, July 11, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company "),  a leading pan-American (ex-US) specialty pharmaceutical company, announced today...

      July 11 2024
      GlobeNewswire Inc.

      Knight Therapeutics Reports First Quarter 2024 Results

      MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported...

      May 09 2024
      GlobeNewswire Inc.

      Knight Therapeutics Inc. announces voting results from the Annual General Meeting

      MONTREAL, May 08, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Corporation") a leading pan-American (ex-US) specialty pharmaceutical company, announced today the...

      May 08 2024
      GlobeNewswire Inc.

      Knight to Present at the 2024 RBC Capital Markets Global Healthcare Conference in New York City

      MONTREAL, May 07, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:  GUD) ("Knight"), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia...

      May 07 2024
      GlobeNewswire Inc.

      Notice of Knight Therapeutics' First Quarter 2024 Results Conference Call

      MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its first quarter 2024...

      May 02 2024
      GlobeNewswire Inc.

      Knight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

      MONTREAL, April 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia...

      April 09 2024
      GlobeNewswire Inc.

      Knight Therapeutics Inc. ranks on The Globe and Mail’s fifth-annual Women Lead Here benchmark of executive gender diversity

      MONTREAL, March 28, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”) is pleased to announce it will be recognized on The Globe and Mail’s 2024 Report on...

      March 28 2024
      GlobeNewswire Inc.

      Knight Therapeutics Reports Fourth Quarter and Year-End 2023 Results

      MONTREAL, March 21, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported...

      March 21 2024
      GlobeNewswire Inc.

      Trading For This Specialty Pharma Company is up Following Second Quarter Results

      This stock is almost a penny stock no longer, as shares moved close to the $5 threshold following the firm’s quarterly announcement. Leading pan-American (ex-US) specialty pharmaceutical...

      August 10 2023
      AllPennyStocks.com
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.122.11640211645.675.885.6463955.74771119CS
      40.336.043956043965.465.885.38466885.60799619CS
      12-0.08-1.362862010225.876.225.38561975.83137177CS
      260.142.477876106195.656.225.21662505.61826666CS
      520.8918.16326530614.96.224.35627775.26988817CS
      1560.5310.07604562745.266.224.281438085.26812895CS
      260-1.68-22.48995983947.478.884.282189995.92217468CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SHIMShimmick Corporation
      $ 3.14
      (51.69%)
      		1.62M
      ASSTAsset Entities Inc
      $ 2.05
      (30.57%)
      		551.92k
      MLGOMicroAlgo Inc
      $ 3.56
      (25.35%)
      		4.59M
      AFARUAura FAT Projects Acquisition Corporation
      $ 14.74
      (19.55%)
      		1.13k
      APVOAptevo Therapeutics Inc
      $ 0.3992
      (19.16%)
      		17.92M
      FIVEFive Below Inc
      $ 85.00
      (-16.72%)
      		37.74k
      HOVRNew Horizon Aircraft Ltd
      $ 0.561
      (-13.69%)
      		13.82k
      QXOQXO Inc
      $ 47.51
      (-12.83%)
      		446
      VRPXVirpax Pharmaceuticals Inc
      $ 1.32
      (-12.58%)
      		116.48k
      LRELead Real Estate Company Ltd
      $ 1.84
      (-12.38%)
      		8.69k
      APVOAptevo Therapeutics Inc
      $ 0.3992
      (19.16%)
      		17.92M
      CEROCERo Therapeutics Holdings Inc
      $ 0.205
      (5.13%)
      		10.63M
      CDTConduit Pharmaceuticals Inc
      $ 0.28
      (11.51%)
      		6.76M
      MLGOMicroAlgo Inc
      $ 3.56
      (25.35%)
      		4.59M
      NVDANVIDIA Corporation
      $ 122.26
      (-3.24%)
      		2.74M

      GUD Discussion

      View Posts
      sumotrader sumotrader 9 years ago
      Loaded 1600 more shares today. GUD is about to take off.
      👍️0
      CommonCents4Dollars CommonCents4Dollars 9 years ago
      This must be some sort of record,.. " the Company reported revenues of $109,608 and net income of $124,981,439."

      http://www.gud-knight.com/en/knight-reports-fourth-quarter-and-year-ended-december-31-2014-results
      👍️0
      CommonCents4Dollars CommonCents4Dollars 9 years ago
      Knight Therapeutics GUD.TO : Mackie Research starts with buy rating; target price of C$12

      http://www.investorvillage.com/groups.asp?mb=6781&mn=83648&pt=msg&mid=14732670
      👍️0
      OneStepAhead OneStepAhead 9 years ago
      On a tear
      👍️0
      CommonCents4Dollars CommonCents4Dollars 9 years ago
      GOD is GUD. :)
      👍️0
      CommonCents4Dollars CommonCents4Dollars 9 years ago
      KHTRF is the OTC Ticker for Americans
      or
      GUD on the TSX for Canadians


      LONG on this one.
      👍️0
      CommonCents4Dollars CommonCents4Dollars 9 years ago
      GUD is flying along nicely,.. Paladin II is in GUD hands, Goodman building another BEAST!
      👍️0
      OneStepAhead OneStepAhead 10 years ago
      GUD Knight Therapeutics

      Knight Therapeutics Inc. ("Knight" or the "Company") (TSX:GUD) today announced that it has entered into a bought deal agreement with a syndicate of underwriters led by GMP Securities L.P. and including Cormark Securities Inc., National Bank Financial Inc., Laurentian Bank Securities Inc., Bloom Burton & Co., Clarus Securities Inc., Mackie Research Capital Corporation and TD Securities Inc. (the "Underwriters"), pursuant to which the Underwriters have agreed to purchase 11,111,120 common shares of the Company (the "Common Shares") at a price of $6.75 per Common Share for gross proceeds to Knight of $75,000,060 (the "Offering"). In addition, the Underwriters will have the option, exercisable for a period of 30 days after the closing date, to acquire up to an aggregate of 1,666,668 additional Common Shares ($11,250,009) at the offering price to cover over-allotments, if any (the "Over-Allotment Option"). If the Over-Allotment Option is exercised in full, the total gross proceeds of the Offering shall be $86,250,069.

      http://www.marketwired.com/press-release/knight-therapeutics-enters-into-agreement-75-million-bought-deal-common-shares-tsx-gud-1973898.htm
      👍️0
      OneStepAhead OneStepAhead 10 years ago
      GUD Knight Therapeutics

      After selling off his specialty pharmaceutical company Paladin Labs Inc. in a deal worth $3-billion, Montreal entrepreneur Jonathan Goodman is starting from scratch with a new drug distribution venture.

      http://www.theglobeandmail.com/globe-investor/investment-ideas/a-fresh-stock-with-a-veteran-face/article17189152/
      👍️0
      Greedy G Greedy G 10 years ago
      TNEN:

      http://stockcharts.com/h-sc/ui?s=TNEN&p=D&b=5&g=0&id=p74917584188
      👍️0

      Your Recent History

      TSX
      GUD
      Knight Therapeutics
      BIT
      I08096
      Intesa Sanpaolo
      XE
      WEL8
      Amundi Index Solutions
      TG
      DWNI
      Deutsche Wohnen
      LSE
      VJPU
      Vanftsejapan
      Delayed Upgrade Clock